What is CG Oncology's quick ratio?

CG Oncology (CGON) reported quick ratio of 31.3× in Q1 2026.

How has CG Oncology's quick ratio changed year-over-year?

CG Oncology's quick ratio increased by 0.9% year-over-year, from 31× to 31.3×.

What is the long-term trend for CG Oncology's quick ratio?

Over 2 years (2023 to 2025), CG Oncology's quick ratio has grown at a 34.3% compound annual growth rate (CAGR), from 13.6× to 24.6×.

What does quick ratio mean?

Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.

CG Oncology CGON Quick ratio

Quick ratio at other companies

PfizerPFE

1.2×0.0×

Johnson & JohnsonJNJ

0.8×-0.3×

Gilead SciencesGILD

1.7×+0.5×

ImmunityBio, Inc.IBRX

6.4×+4.3×

Cogent Biosciences, Inc.COGT

15.1×+10.0×

Tango TherapeuticsTNGX

27.4×+21.1×

Other financials

Income statement

See full

Revenue$1.1M+1,983%

Operating income-$66.4M-57.3%

Net income-$60.2M-74.7%

EPS (diluted)-$0.71-57.8%

Balance sheet

See full

Cash & equivalents$33.7M-18.7%

Total debt$7.6M+631%

Total equity$1.1B+54.9%

Total assets$1.1B+55.9%

Cash flow

See full

Operating cash flow-$56.9M-94.5%

CapEx$304.0K+1,800%

Free cash flow-$57.2M-95.4%

Valuation

See full

Market cap$5.39B+206%

Enterprise value$5.36B+212%

P/S1,062.4×-1,596×

Profitability

See full

Operating margin-4,239%-1,872pp

Net margin-3,682.6%-1,601pp

FCF margin-3,163.8%-1,351pp

Returns & leverage

See full

Return on equity-20.8%+7.1pp

Debt / equity0×0.0×

Current ratio31.3×+0.3×

Where this comes from

Calculated from CG Oncology’s reported figures.

quick assets/total current liabilities=31.3×

Based on the most recent quarter.

The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about CG Oncology's quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CG Oncology's quick ratio?: CG Oncology (CGON) reported quick ratio of 31.3× in Q1 2026.
How has CG Oncology's quick ratio changed year-over-year?: CG Oncology's quick ratio increased by 0.9% year-over-year, from 31× to 31.3×.
What is the long-term trend for CG Oncology's quick ratio?: Over 2 years (2023 to 2025), CG Oncology's quick ratio has grown at a 34.3% compound annual growth rate (CAGR), from 13.6× to 24.6×.
What does quick ratio mean?: Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.